CI
Clal Insurance’s Evogene EVGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-1
| Closed | – | – | 207 |
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 215 |
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 217 |
|
2021
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 217 |
|
2020
Q3 | – | Sell |
-591,264
| Closed | -$591K | – | 145 |
|
2020
Q2 | $591K | Hold |
591,264
| – | – | 0.01% | 113 |
|
2020
Q1 | $698K | Buy |
591,264
+590,365
| +65,669% | +$697K | 0.02% | 97 |
|
2019
Q4 | $591K | Sell |
899
-590,365
| -100% | -$388M | 0.63% | 42 |
|
2019
Q3 | $934K | Hold |
591,264
| – | – | 0.02% | 93 |
|
2019
Q2 | $952K | Hold |
591,264
| – | – | 0.02% | 84 |
|
2019
Q1 | $1.08M | Sell |
591,264
-8,717
| -1% | -$16K | 0.03% | 78 |
|
2018
Q4 | $1.19M | Hold |
599,981
| – | – | 0.03% | 71 |
|
2018
Q3 | $1.87M | Hold |
599,981
| – | – | 0.05% | 58 |
|
2018
Q2 | $1.72M | Hold |
599,981
| – | – | 0.04% | 56 |
|
2018
Q1 | $1.91M | Hold |
599,981
| – | – | 0.05% | 55 |
|
2017
Q4 | $1.84M | Hold |
599,981
| – | – | 0.05% | 56 |
|
2017
Q3 | $2.66M | Hold |
599,981
| – | – | 0.06% | 53 |
|
2017
Q2 | $3.04M | Hold |
599,981
| – | – | 0.06% | 56 |
|
2017
Q1 | $3.21M | Hold |
599,981
| – | – | 0.07% | 50 |
|
2016
Q4 | $3.06M | Hold |
599,981
| – | – | 0.06% | 50 |
|
2016
Q3 | $3.83M | Hold |
599,981
| – | – | 0.09% | 62 |
|
2016
Q2 | $3.74M | Hold |
599,981
| – | – | 0.1% | 70 |
|
2016
Q1 | $3.91M | Sell |
599,981
-19
| -0% | -$124 | 0.11% | 64 |
|
2015
Q4 | $4.83M | Hold |
600,000
| – | – | 0.13% | 60 |
|
2015
Q3 | $4.95M | Hold |
600,000
| – | – | 0.13% | 60 |
|
2015
Q2 | $5.3M | Hold |
600,000
| – | – | 0.12% | 66 |
|
2015
Q1 | $5.29M | Hold |
600,000
| – | – | 0.12% | 70 |
|
2014
Q4 | $5.53M | Buy |
+600,000
| New | +$5.53M | 0.13% | 73 |
|